ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase

Clinical trial NCT04912505 · COMPLETED

Trial details

NCT number: NCT04912505
Sponsor: University Hospital, Toulouse
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Purpura, Thrombocytopenic

Start date: 2023-01-16
Primary completion: 2024-01-02
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.